Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection

OBJECTIVES: In some patients the immune response triggered by SARS-CoV-2 is unbalanced, presenting an acute respiratory distress syndrome which in many cases requires intensive care unit (ICU) admission. The limitation of ICU beds has been one of the major burdens in the management around the world;...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Rev Esp Quimioter
Main Authors: Moreno-García, Estela, Rico, Verónica, Albiach, Laia, Agüero, Daiana, Ambrosioni, Juan, Bodro, Marta, Cardozo, Celia, Chumbita, Mariana, De la Mora, Lorena, García-Pouton, Nicole, Garcia-Vidal, Carolina, González-Cordón, Ana, Hernández-Meneses, Marta, Inciarte, Alexy, Laguno, Montse, Leal, Lorna, Linares, Laura, Macaya, Irene, Meira, Fernanda, Mensa, Josep, Moreno, Antonio, Morata, Laura, Puerta-Alcalde, Pedro, Rojas, Jhon, Solá, Montse, Torres, Berta, Torres, Manuel, Tomé, Adrià, Tuset, Montse, Castro, Pedro, Fernández, Sara, Nicolás, Josep Maria, Almuedo-Riera, Alex, Muñoz, Jose, Fernandez-Pittol, Mariana, Marcos, Maria Angeles, Soy, Dolors, Martínez, José Antonio, García, Felipe, Soriano, Alex
Format: Artigo
Jezik:Inglês
Izdano: Sociedad Española de Quimioterapia 2021
Teme:
Original
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8179941/
https://ncbi.nlm.nih.gov/pubmed/33829722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.37201/req/037.2021
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki